✦ LIBER ✦

S86 Results from the first phase I clinical study of the novel Ii-Key/HER-2(776–790) hybrid peptide vaccine in patients with prostate cancer

✍ Scribed by S. Mpisias; T. Kalogeropoulos; E. Koutsiaris; A. Rempelakos; A. Konandreas; K. Georgakopoulou; S. Perez; K. Baxevanis; T. Arvanitakis; A. Thanos

Book ID: 119620527
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 95 KB
Volume: 8
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(09)74967-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

950 RESULTS FROM THE FIRST PHASE I CLINI

950 RESULTS FROM THE FIRST PHASE I CLINICAL STUDY OF THE NOVEL II-KEY/HER-2/NEU (776–790) HYBRID PEPTIDE VACCINE IN PATIENTS WITH PROSTATE CANCER

✍ S. Mpisias; T. Karaolides; A. Pappas; E. Koutsiaris; A. Konandreas; S. Perez; V. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 96 KB

POD-04.04: Phase I Clinical Study of the

POD-04.04: Phase I Clinical Study of the Novel LI-Key/HER-2(776-790) Hybrid Peptide Vaccine in Patients with Prostate Cancer

✍ S. Bisias; K. Georgakopoulou; A. Rempelakos; E. Koutsiaris; A. Papas; T. Arvanit 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Results of the first phase 1 clinical tr

Results of the first phase 1 clinical trial of the HER-2/neu peptide (GP2) vaccine in disease-free breast cancer patients : United States Military Cancer Institute Clinical Trials Group Study I-04

✍ Mark G. Carmichael; Linda C. Benavides; Jarrod P. Holmes; Jeremy D. Gates; Eliza 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 1 views